25,775 Shares in Phibro Animal Health Co. (NASDAQ:PAHC) Bought by Smith Group Asset Management LLC

Smith Group Asset Management LLC acquired a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,775 shares of the company's stock, valued at approximately $541,000. Smith Group Asset Management LLC owned about 0.06% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also added to or reduced their stakes in PAHC. Jacobs Levy Equity Management Inc. raised its holdings in shares of Phibro Animal Health by 116.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company's stock worth $4,330,000 after purchasing an additional 103,491 shares during the period. Dana Investment Advisors Inc. raised its stake in shares of Phibro Animal Health by 17.2% in the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company's stock valued at $8,619,000 after buying an additional 75,546 shares during the period. Algert Global LLC lifted its position in shares of Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after buying an additional 59,850 shares during the last quarter. AXA S.A. bought a new position in shares of Phibro Animal Health during the 2nd quarter worth $906,000. Finally, Dimensional Fund Advisors LP increased its holdings in Phibro Animal Health by 5.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company's stock worth $13,005,000 after acquiring an additional 42,086 shares during the last quarter. Institutional investors own 99.34% of the company's stock.

Analysts Set New Price Targets

PAHC has been the subject of a number of research reports. Barclays increased their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a report on Wednesday. Finally, Morgan Stanley boosted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health presently has a consensus rating of "Hold" and an average price target of $20.50.

Phibro Animal Health Price Performance

Shares of PAHC traded down $0.17 during midday trading on Friday, hitting $21.81. 164,917 shares of the company traded hands, compared to its average volume of 131,648. The stock has a 50-day moving average of $21.98 and a 200-day moving average of $21.54. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health Co. has a one year low of $10.03 and a one year high of $25.98. The firm has a market cap of $883.31 million, a P/E ratio of 50.72, a PEG ratio of 0.56 and a beta of 0.53.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.12. The business had revenue of $260.40 million for the quarter, compared to analysts' expectations of $277.76 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. During the same period in the prior year, the company posted $0.14 EPS. As a group, sell-side analysts predict that Phibro Animal Health Co. will post 1.62 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were paid a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.20%. Phibro Animal Health's dividend payout ratio is currently 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.